Formulation and Evaluation of Nanostructured Lipid Carriers (NLCS) Containing Thymoquinone

Abstract

Nanotherapeutics is increasingly dominating worldwide research and is regarded as a new therapy paradigm in the medical industry. This study outlines the creation of a stable nanostructured lipid carrier (NLC) technology for thymoquinone delivery. This work seeks to construct gelatin-coated nanostructured lipid carriers (NLC) for encapsulating sage extract, with the objective of enhancing the quality characteristics of beef burger samples. Nanostructured lipid carriers (NLC) were synthesized using the hot homogenization ultrafiltration method and then assessed for particle size, zeta potential, polydispersity index (PDI), encapsulation efficiency (EE), and in vitro drug release.